Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States

data from the observational National LymphoCare Study

Brian K. Link, Bann mo Day, Xiaolei Zhou, Andrew D. Zelenetz, Keith L. Dawson, James R Cerhan, Christopher R. Flowers, Jonathan W. Friedberg

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)660-663
Number of pages4
JournalBritish Journal of Haematology
Volume184
Issue number4
DOIs
StatePublished - Feb 1 2019

Fingerprint

Follicular Lymphoma
Therapeutics
Rituximab

Keywords

  • B-cell neoplasms
  • clinical results in lymphoma
  • immunotherapeutic approaches
  • rituximab
  • treatment patterns

ASJC Scopus subject areas

  • Hematology

Cite this

Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States : data from the observational National LymphoCare Study. / Link, Brian K.; Day, Bann mo; Zhou, Xiaolei; Zelenetz, Andrew D.; Dawson, Keith L.; Cerhan, James R; Flowers, Christopher R.; Friedberg, Jonathan W.

In: British Journal of Haematology, Vol. 184, No. 4, 01.02.2019, p. 660-663.

Research output: Contribution to journalLetter

Link, Brian K. ; Day, Bann mo ; Zhou, Xiaolei ; Zelenetz, Andrew D. ; Dawson, Keith L. ; Cerhan, James R ; Flowers, Christopher R. ; Friedberg, Jonathan W. / Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States : data from the observational National LymphoCare Study. In: British Journal of Haematology. 2019 ; Vol. 184, No. 4. pp. 660-663.
@article{6114a427110646c69d2461fca0150205,
title = "Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study",
keywords = "B-cell neoplasms, clinical results in lymphoma, immunotherapeutic approaches, rituximab, treatment patterns",
author = "Link, {Brian K.} and Day, {Bann mo} and Xiaolei Zhou and Zelenetz, {Andrew D.} and Dawson, {Keith L.} and Cerhan, {James R} and Flowers, {Christopher R.} and Friedberg, {Jonathan W.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1111/bjh.15149",
language = "English (US)",
volume = "184",
pages = "660--663",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States

T2 - data from the observational National LymphoCare Study

AU - Link, Brian K.

AU - Day, Bann mo

AU - Zhou, Xiaolei

AU - Zelenetz, Andrew D.

AU - Dawson, Keith L.

AU - Cerhan, James R

AU - Flowers, Christopher R.

AU - Friedberg, Jonathan W.

PY - 2019/2/1

Y1 - 2019/2/1

KW - B-cell neoplasms

KW - clinical results in lymphoma

KW - immunotherapeutic approaches

KW - rituximab

KW - treatment patterns

UR - http://www.scopus.com/inward/record.url?scp=85060100881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060100881&partnerID=8YFLogxK

U2 - 10.1111/bjh.15149

DO - 10.1111/bjh.15149

M3 - Letter

VL - 184

SP - 660

EP - 663

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -